Lantern Pharma Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dallas, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Lantern Pharma Inc. has filed 246 SEC EDGAR filings since 14 Jan 2019

SEC filing history

Showing 126-150 of 246 matching filings.

Per page
25
Current page
6
10-Q File 001-39318

10-Q filing

Filing date
07 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
4

4 filing

Filing date
24 Oct 2022
Reporting date
20 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Sep 2022
Reporting date
02 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Sep 2022
Reporting date
02 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Aug 2022
Reporting date
06 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39318

10-Q filing

Filing date
08 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
3

3 filing

Filing date
17 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
14 Jun 2022
Reporting date
08 Jun 2022
Next action
Verify source filing
DEFA14A File 001-39318

DEFINITIVE ADDITIONAL MATERIALS

Filing date
03 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39318

QUARTERLY REPORT

Filing date
03 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
03 May 2022
Reporting date
03 May 2022
Next action
Verify source filing
DEF 14A File 001-39318

DEFINITIVE PROXY STATEMENT

Filing date
27 Apr 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
26 Apr 2022
Reporting date
20 Apr 2022
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
25 Apr 2022
Reporting date
25 Apr 2022
Next action
Verify source filing
SC 13D/A File 005-91536

SC 13D/A

Filing date
22 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
22 Mar 2022
Reporting date
22 Mar 2022
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Mar 2022
Reporting date
17 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39318

ANNUAL REPORT

Filing date
10 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
10 Mar 2022
Reporting date
10 Mar 2022
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
24 Jan 2022
Reporting date
24 Jan 2022
Next action
Verify source filing
SC 13G/A File 005-91536

LANTERN PHARMA INC.

Filing date
11 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
22 Nov 2021
Reporting date
22 Nov 2021
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Nov 2021
Reporting date
04 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .